Proposal for translational analysis and development of clinical radiolabeled immunoglobulin therapy

Bierman, 1993, Yttrium-90-labeled antiferritin followed by high-dose chemotherapy and autologous bone marrow transplantation for poor prognosis Hodgkin's disease, J. Clin. Oncol., 11, 698, 10.1200/JCO.1993.11.4.698 Buchsbaum, 1994, Fractionated radioimmunotherapy of human colon carcinoma xenografts with 131-I-CC49 monoclonal antibody, J. Immunother., 16, 156, 10.1097/00002371-199408000-00041 Chen, 1994, Hum. Antibodies Hybridomas, 5, 131 Epenetos, 1987, Antibody-guided irradiation of advanced ovarian cancer with intraperitoneally administered radiolabeled monoclonal antibodies, J. Clin. Oncol., 5, 1890, 10.1200/JCO.1987.5.12.1890 Fowler, 1990, Radiobiological aspects of low dose rates in immunotherapy, Int. J. Radiat. Oncol. Biol. Phys., 18, 1261, 10.1016/0360-3016(90)90467-X Freedman, 1991, Development of a cell surface-reacting human monoclonal antibody agent in ovarian carcinoma, Hybridoma, 10, 21, 10.1089/hyb.1991.10.21 Goldenberg, 1989, Future role of monoclonal antibodies in oncological diagnosis and therapy, 19, 332 Grossbard, 1992, Monoclonal antibody-based therapies of leukemia and lymphoma, Blood, 80, 863, 10.1182/blood.V80.4.863.863 Herbst, 1995, Survival of patients with resistant Hodgkin's disease after polyclonal yttrium-90-labeled antiferritin treatment, J. Clin. Oncol., 13, 2394, 10.1200/JCO.1995.13.9.2394 Ingold, 1965, Radiation hepatitis, Am. J. Radiol., 93, 200 Jaeckle, K. A. Paraneoplastic neurological diseases in cancer of the nervous system. Editor: V. Levin. Churchill Livingstone, New York (in press). Lamki, 1990, Metastatic colorectal cancer: radioimmunoscintigraphy with a stabilized In-111-labeled F(ab′)2 fragment of an anti CEA monoclonal antibody, Radiology, 174, 147, 10.1148/radiology.174.1.2294542 Larson, 1987, Lymphoma, melanoma, colon cancer diagnosis and treatment with radiolabeled monoclonal antibodies, Radiology, 165, 297, 10.1148/radiology.165.2.3498971 Leichner, 1993, Tumor dosimetry in radioimmunotherapy: methods of calculation for beta particles, Med. Phys., 29, 529, 10.1118/1.597048 Leichner, 1993, An overview of imaging techniques and physical aspects of treatment planning in radioimmunotherapy, Med. Phys., 20, 569, 10.1118/1.597051 Lenhard, 1985, Isotopic immunoglobulin: a new systemic therapy for advanced Hodgkin's disease, J. Clin. Oncol., 3, 1296, 10.1200/JCO.1985.3.10.1296 Markoe, 1990, Treatment of gastrointestinal cancer using monoclonal antibodies, Front. Radiat. Ther. Oncol., 24, 214, 10.1159/000417788 Molthoff, 1992, Influence of dose and schedule on the therapeutic efficacy of 131-I-labeled monoclonal antibody 139H2 in a human ovarian cancer xenograft model, Int. J. Cancer, 50, 474, 10.1002/ijc.2910500324 Murray, 1994, Phase II radioimmunotherapy trial with 131-I-CC49 in colorectal cancer, Cancer, 73, 1057, 10.1002/1097-0142(19940201)73:3+<1057::AID-CNCR2820731345>3.0.CO;2-3 Olive, 1993, Therapeutic applications of anti-CD4 antibodies, Crit. Rev. Ther. Drag Carrier Syst., 10, 29 Press, 1990, High dose radioimmunotherapy of B cell lymphoma, Front. Radiat. Ther. Oncol., 24, 104 Quadri, 1993, Evaluation of indium-111 and yttrium-90 labeled linker-immunoconjugates in nude mice and dogs, J. Nucl. Med., 34, 938 Quadri, 1992, A convenient synthesis of 2-p-aminobenzyl-3-methyl and 2-p-aminobenzyl-3-benzyl derivatives of diethylenetriaminepentaacetic acid (DTPA): carbon backbone-modified bifunctional chelating agents, Bioorg. Med. Chem. Lett., 2, 1661, 10.1016/S0960-894X(00)80451-5 Quadri, 1993, Assessment of radiolabeled stabilized F(ab′)2 fragments of monoclonal antiferritin antibody in a nude mouse model, J. Nucl. Med., 34, 2152 Quadri, 1995, Biodistribution and tumor localization of indium-111-labeled unmodified and modified F(ab′)2 fragments of human monoclonal IgM (16.88) in a nude mouse model, Nucl. Med. Biol., 22, 413, 10.1016/0969-8051(94)00137-9 Quadri, 1993, Preclinical evaluation of intravenously administered indium-111 and yttrium-90 labeled B72.3 immunoconjugate (GYK-DTPA) in beagle dogs, Nucl. Med. Biol., 10, 559, 10.1016/0969-8051(93)90024-O Quadri, 1995, Preclinical analysis of intraperitoneal administration of indium-111-labeled human monoclonal IgM (AC6C3), Cancer Res., 55, 5736s Riva, 1994, Intralesional radioimmunotherapy of malignant gliomas: an effective treatment in recurrent tumors, Cancer, 73, 1076, 10.1002/1097-0142(19940201)73:3+<1076::AID-CNCR2820731347>3.0.CO;2-Z Scheinberg, 1991, A Phase I trial of monoclonal antibody M195 in acute myelogeneous leukemia: specific bone marrow targeting and internalization of radionuclides, J. Clin. Oncol., 24, 194 Schlom, 1991, Monoclonal antibodies. They are more and less than you think, 95 Schlom, 1990, Advantage of dose fractionation in monoclonal antibody targeted radioimmunotherapy, J. Natl. Cancer Inst., 82, 763, 10.1093/jnci/82.9.763 Stewart, 1995, Radiation nephropathy after abdominal irradiation or total body irradiation, Radiat. Res., 143, 235, 10.2307/3579208 Vaughan, 1986, Illusions of tumor killing using radiolabeled antibodies, Lancet, 1, 1492, 10.1016/S0140-6736(86)91520-5 Vriesendorp, 1992, Selection of reagents for human radioimmunotherapy, Int. J. Radiat. Oncol. Biol. Phys., 22, 37, 10.1016/0360-3016(92)90980-V Vriesendorp, 1995, A review of five consecutive studies of radiolabeled immunoglobulin therapy in patients with endstage Hodgkin's disease, Cancer Res., 55, 5888s Vriesendorp, 1992, Radioimmunoglobulin therapy, 84 Vriesendorp, 1993, Fractionated intravenous administration of site-specific yttrium-90 labeled B72.3 GYK DTPA immunoconjugate in beagle dogs, Nucl. Med. Biol., 20, 571, 10.1016/0969-8051(93)90025-P Vriesendorp, 1991, Phase I-II studies of yttrium-labeled antiferritin for end-stage Hodgkin's disease including RTOG 87-01, J. Clin. Oncol., 9, 918, 10.1200/JCO.1991.9.6.918 Vriesendorp, 1976, Similarities between HL-A and major histocompatibility complexes of subhuman primates Vriesendorp, 1993, Radioimmunotherapy for bone marrow transplantation patients, 98 Waldman, 1989, Manipulation of T-cell responses with monoclonal antibodies, Annu. Rev. Immunol., 7, 407, 10.1146/annurev.iy.07.040189.002203 Wang, 1995, Liver toxicity induced by combined external beam irradiation and radioimmunoglobulin therapy, Radiat. Res., 141, 294, 10.2307/3579006 Wilbur, 1991, Potential use of alpha emitting radionuclides in the treatment of cancer, Antibody Immunoconjug. Radiopharm., 4, 85